March 27, 2019
Clinigen’s Foscavir® gains approval for HHV-6 encephalitis in Japan
BURTON-UPON-TRENT, England–(BUSINESS WIRE)–Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, announces that Foscavir (foscarnet sodium) has…